Now FDA Expands Indication For Medtronic’s CRT-D Devices To Treat Mildly Symptomatic Heart Failure Patients

Medtronic declares itself pleased, but in reality must be absolutely delighted by the news that FDA has allowed it to expand the indications for its CRT-D resynchronisation/defibrillator devices to now include patients with mildly symptomatic heart failure.

Most read

Latest

^